1. Home
2. Symposiums (SBIMC)
3. Symposiums
4. 19ième symposium

19ième symposium

CONTROVERSIES AND COMPLEMENTARITY OR WHAT DO WE REALLY LEARN FROM OUR NIEGHBOURS?

• Antimicrobial resistance and usage patterns in Europe: focus on Dutch-Belgian differences and complementarities. Lessons for the future. [Dominique MONNET (Statens Serum Institut, Kobnhavn, Danemark)
• MRSA control: which policy? [Andreas VOSS (Radboud UMC, Nijmegen, Pays-Bas)]
• MRSA control: Belgian policy. [Marc STRUELENS (Hôpital Erasme - ULB, Bruxelles)]
• Microbiologist-infectiologist relationship: synergy or antagonism? [Dirk VOGELAERS (UZ Gent, Gand)]
• Microbiologist-infectiologist relationship: synergy or antagonism? [Henri VERBRUGH (Erasmus MC, Rotterdam, Pays-Bas)]
• HIV genotyping: yes or no? [Charles BOUCHER (UMC Utrecht, Utrecht, Pays-Bas)]
• Genotypic resistance testing: yes or no? [Stéphane DE WIT (CHU Saint-Pierre, Bruxelles)]
• Surgical antimicrobial prophylaxis in the Netherlands. [Inge GYSSENS (Erasmus MC, Rotterdam, Pays-Bas)]
• From national to local guidelines: prophylaxis in surgery. The Belgian experience. [Jean-Paul SION (AZ Monica, Anvers)]
• Acute exacerbations of COPD: the Dutch perspective. [Andy HOEPELMAN (UMC Utrecht, Utrecht, Pays-Bas)]
• Acute exacerbations of COPD: the Belgian perspective. [Yvan VALCKE (AZ Maria Middelares, Saint-Nicolas)]
• MIC based therapies: why bother? [Henri VERBRUGH (Canisius Wilhelmina Ziekenhuis, Nijmegen, Pays-Bas)]
• MIC based therapies. [Willy PEETERMANS (UZ Leuven, Louvain)]